tiprankstipranks
Trending News
More News >
Hightide Therapeutics Inc (HK:2511)
:2511
Hong Kong Market

Compare Hightide Therapeutics Inc (2511) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Hightide Therapeutics Inc
HK$3.05
HK$1.38B
-3.89
144.14%
Brii Biosciences Limited
HK$1.44
HK$1.10B
-2.73
36.94%
Genor Biopharma Holdings Limited
HK$3.06
HK$5.20B
58.33
37.04%
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$1.93B
238.10
38.89%
JW (Cayman) Therapeutics Co. Ltd.
HK$2.50
HK$1.12B
-1.64
112.70%
Mabpharm Limited
HK$0.50
HK$2.27B
-76.39
107.55%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2511
Hightide Therapeutics Inc
2.71
1.66
158.10%
HK:2137
Brii Biosciences Limited
1.52
0.43
39.45%
HK:6998
Genor Biopharma Holdings Limited
2.59
0.76
41.53%
HK:1875
TOT BIOPHARM International Co. Ltd.
2.50
0.70
38.89%
HK:2126
JW (Cayman) Therapeutics Co. Ltd.
2.68
1.40
109.38%
HK:2181
Mabpharm Limited
0.55
0.30
120.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts